CDNA Q3 2020 Earnings — CareDx, Inc Revenue & Financial Results | Market Cap Arena

CDNACareDx, Inc

$858M

Q3 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$53M+57.8% YoY

Gross Profit

$37M68.5% margin

Operating Income

-$3M-5.4% margin

Net Income

-$3M-5.3% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+27.7%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$971,000

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$354M

Total Liabilities

$85M

Stockholders' Equity

$269M

Cash & Equivalents

$214M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$34M	+57.8%
Gross Profit	$37M	$22M	+63.8%
Operating Income	-$3M	-$7M	+56.9%
Net Income	-$3M	-$2M	-55.4%

Geographic Segments

UNITED STATES

$45M96%

Europe

$2M4%

Rest Of The World

$90,0000%